We are live on ! Find out more
IVMX

Institutional Venture Management XII Portfolio holdings

AUM $7.07M
1-Year Est. Return 53.31%
This Fund
S&P 500
This Quarter Est. Return
-12.21%
1 Year Est. Return
-53.31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$184M
AUM Growth
-$560M
Cap. Flow
-$434M
Cap. Flow %
-235.72%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TWTR
Twitter, Inc.
TWTR
+$432M
2
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$1.98M

Sector Composition

Rank Sector Weight
1 Communication Services 100%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWTR
1
DELISTED
Twitter, Inc.
TWTR
$184M 100%
4,490,820
-11,404,633
-72% -$432M
ZNGA
2
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
-460,858
Closed -$1.98M

Similar funds

Institutional Venture Management XII's Q2 2014 Portfolio in Review

As of Q2 2014, Institutional Venture Management XII held 2 positions worth $184M, down 75% from $744M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Institutional Venture Management XII withdrew a net $434M in Q2 2014, closing 1 position and reducing 1 holding. Its most notable exit was ZYNGA INC. CL A COMMON, an estimated $1.98M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 100% of assets, up from 100% a quarter earlier, followed by Technology.

  • Institutional Venture Management XII's biggest Q2 2014 reduction was Twitter, Inc., cutting an estimated $432M.
  • Institutional Venture Management XII fully exited ZYNGA INC. CL A COMMON in Q2 2014, selling an estimated $1.98M.
  • Institutional Venture Management XII's ten largest holdings make up 100% of its $184M portfolio in Q2 2014.
  • Institutional Venture Management XII opened 0 new positions and closed 1 in Q2 2014.
  • Institutional Venture Management XII's portfolio value fell 75% quarter-over-quarter to $184M.

Based on Institutional Venture Management XII's 13F filing for Q2 2014, filed 11 Aug 2014.